Delcath Systems Inc (DCTH)
Official siteHEALTHCARE • MEDICAL DEVICES • NASDAQ
Market Cap: $714.89M
Last updated: Nov 17, 2026 at 4:15 PM ET
Delcath Systems Inc (DCTH) Stock Chart
Delcath Systems (DCTH) has a latest price of $19.37 on Nov 17, 2026, 13.9% below its 52-week high of $22.51. Its price rose 116.9% over the past 12 months. The month-end price fell 100.0% over the 10 years through Oct 2026, a compound annual decline of 81.1%.
Price Chart
From Oct 2016 to Oct 2026, its highest month-end close was $257,389,162.56 in Nov 2016 and its lowest $2.75 in Nov 2023, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart DCTH with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for DCTH.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price rose 12.9%, and over 6 months it rose 78.5%. The month-end price rose 345.7% over the 3 years through Oct 2026, a compound annual rate of 64.6%.
| Period | Change |
|---|---|
| 1 month | +34.8% |
| 3 months | +12.9% |
| 6 months | +78.5% |
| 12 months | +116.9% |
| 12 months, with dividends | +116.9% |
| Period | Change | Per year |
|---|---|---|
| 3 years | +345.7% | +64.6% |
| 5 years | +26.4% | +4.8% |
| 10 years | -100.0% | -81.1% |
Price by Year
Its best calendar year was 2024, when the price rose 189.4%, and its weakest was 2017, when it fell 100.0%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $14.04 | +39.0% |
| 2025 | $10.10 | -16.1% |
| 2024 | $12.04 | +189.4% |
| 2023 | $4.16 | +15.6% |
| 2022 | $3.60 | -53.5% |
| 2021 | $7.75 | -56.8% |
| 2020 | $17.92 | -15.7% |
| 2019 | $21.25 | -89.4% |
| 2018 | $200.07 | -99.4% |
| 2017 | $32,142.86 | -100.0% |
Trading Range
The price is 20.9% above its 50-day average of $16.02 and 51.2% above its 200-day average of $12.81.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $19.37 | |
| 52-week high | $22.51 | -13.9% |
| 52-week low | $8.12 | +138.5% |
| 50-day average | $16.02 | +20.9% |
| 200-day average | $12.81 | +51.2% |
Price Risk
Over 3 years, its largest fall from a peak was 54.8%.
| Measure | Value |
|---|---|
| 1-year beta | 1.72 |
| Largest fall, 1 year | -21.7% |
| Largest fall, 3 years | -54.8% |
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About DCTH
What is DCTH's 1-year price change?
Delcath Systems's price rose 116.9% over the past 12 months. With dividends included, the 12-month total return was 116.9%.
What is DCTH's 5-year price change?
Delcath Systems's month-end price rose 26.4% over the 5 years through Oct 2026, a compound annual rate of 4.8%. These figures leave out dividends.
What is DCTH's 52-week high and low?
Delcath Systems's 52-week high is $22.51 and its 52-week low is $8.12. Its latest price of $19.37 on Nov 17, 2026 is 13.9% below the high.
What is DCTH's beta?
Delcath Systems's 1-year beta against the S&P 500 is 1.72, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 21.7%.
Is the DCTH chart free?
Yes. Advanced Charting for DCTH is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
DCTH pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors